Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |